Efficacy Study of Inecalcitol in Combination With Decitabine in Acute Myeloid Leukemia Patients Unfit for Standard Chemotherapy

Trial Profile

Efficacy Study of Inecalcitol in Combination With Decitabine in Acute Myeloid Leukemia Patients Unfit for Standard Chemotherapy

Recruiting
Phase of Trial: Phase II

Latest Information Update: 13 Sep 2017

At a glance

  • Drugs Inecalcitol (Primary) ; Decitabine
  • Indications Acute myeloid leukaemia
  • Focus Therapeutic Use
  • Sponsors Hybrigenics
  • Most Recent Events

    • 30 Jun 2017 Planned primary completion date changed from 1 Jun 2018 to 1 Dec 2018.
    • 12 May 2017 According to a Hybrigenics media release, the company expects data from this trial in first half of 2019 (H119).
    • 13 Sep 2016 According to a Hybrigenics media release, first patient has been enrolled in France.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top